Navigation Links
Dr. Yu Yamaguchi named recipient of the Humanitarian Scientific Achievement Award
Date:10/25/2007

Burnham Institute for Medical Research Professor Yu Yamaguchi, M.D., Ph.D., was recently awarded The Humanitarian Scientific Achievement Award by the MHE Research Foundation. The focus of the foundation is to find a cure for Multiple Hereditary Exostoses, a rare genetic bone disorder. The disorder causes people to grow exostoses (bone tumors) on their bones. MHE patients can also suffer from non-skeletal medical issues including mental and neurological issues. At this time, there is no treatment or cure. Surgery, physical therapy and pain management are currently the only options in management of the condition.

Mutations in a gene known as EXT1 cause MHE. Dr. Yamaguchi created a mouse model, in which the EXT1 gene can be experimentally disrupted in tissues and organs of interest. His research has provided insights into why MHE patients suffer from non-skeletal medical problems. Dr. Yamaguchi has recently shown that mutations in the EXT1 gene can cause dysfunction of nerve cells, providing a clue as to why MHE patients sometimes associate mental and neurological symptoms. Today, the mouse model is being used in more than 20 laboratories around the world, helping researchers explore the function of the EXT1 gene in a variety of organs and tissues.

Dr. Yu Yamaguchi has expanded the frontiers of understanding of MHE, said Sarah Ziegler, MHE Research Foundation Vice President. These insights also suggest potential novel approaches that can be explored in order to make the dream of a treatment into a reality. Ziegler is also the mother of a son with MHE.

A crystal plaque commemorating the award was presented to Dr. Yamaguchi during the Foundation's FUNTASIA Research Banquet held on September 30, 2007 in Brooklyn, New York. Dr. Yamaguchi was also presented citations and proclamations from U.S. Congress, New York State Senate, and the Borough of Brooklyn.


'/>"/>

Contact: Andrea Moser
amoser@burnham.org
858-646-3146
Burnham Institute
Source:Eurekalert

Page: 1

Related medicine news :

1. UP government decides to suspend doctor named in sting operation
2. Yale Researchers Named Ellison Foundation Senior Scholars in Aging
3. Brian Lara Opens Cancer Center Named After Him
4. Bat Virus Renamed After Protests from Malaysia State
5. Transfer Of Rabies Virus Possible From Organ Donor To Recipient
6. Kidney Donors Health Can Cause Anxiety Among Kidney Recipients
7. Kidney transplant donor and recipients need to talk it out
8. Negative Impact Of Hepatitis C Infection In Renal Transplant Recipients
9. Medical Breakthrough - Kidney Transplant Recipient Survives Without Drugs
10. TNF Protein Can Predict GVHD Bone Marrow Transplant Recipients
11. Kidney Transplant Recipients Tardy In Taking Vital Medications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)... Though the number of jobs created i... companies reported a different kind of slowdown: ...s months. , Seattle, WA (...created in the medical field slowed in June overal...ind of slowdown that will be music to the ears of ...
(Date:7/25/2008)... supporting the US Department of Defense and Feder... Phoenix. Operation Golden Phoenix is a, four-da...ned to assist, federal, state and local agencies w...os. Dataline is providing a vital, ad-hoc, secure ... use during the exercise., NORFOLK, Va., July 25 ...
(Date:7/25/2008)...elationship Based on Significant Improvements in M...MDdatacor, Inc., a leader in health,care quality m..., today,announced it has entered into a long-term ...rt Wellmark,s Collaboration on Quality(SM) Incent ...ion between Wellmark and,primary care clinicians t...
(Date:7/25/2008)...URG, Ill., July 25 /PRNewswire/ -- Sagent Pharmace...utical company, today announced that it,has launch...arrhythmic,indicated for the treatment and prophyl...ion and hemodynamically unstable ventricular,tachy... heart beat.,Sagent,s amiodarone HCl injection wil...
Breaking Medicine News(10 mins):Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 2Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 3Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3
...V and AIDS in India says that women and children a...the most likely one to be withdrawn// from school ...h AIDS. The National AIDS Control Organisation (NA...llion of the 5.2 million HIV/AIDS cases in India i...
... recently been developed by scientists. This appro...many malignancies before// they turn dangerous. Th... they have applied this technique to detect leukem...atic approach to diagnosing cancer at the molecula...
...researchers at the MassGeneral Institute for Neuro...bitor of an enzyme known as Poly //(ADP-ribose) po...untington’s disease affected cells from undergoing...rugs can be developed to treat Huntington's diseas...
...launched an International Stem Cell Research Insti...em cell research. // The academic medical center a...lopmental geneticist Nissim Benvenisty, M.D., Ph.D...g with David I. Meyer, Ph.D., vice president of Re...
Other Medicine News:Health News:New Technique To Diagnose Cancer At Molecular Level 2Health News:Targeting PARP1 Is Effective In Protecting HD Cells from Damage 2Health News:Center Launches New International Stem Cell Research Institute 2
(Date:7/23/2008)... SAN FRANCISCO, July 23 /- InCode Bio... company, today announced preclinical test,results...idate rC3-1 for,the treatment of the rare chronic ... (PNH). The complete results will be presented at ...l, Switzerland, September 28,2008., The only tre...
(Date:7/22/2008)... - Strong efficacy results from a multi-center 293....com , Toronto Stock Exchange Symbol: CYT, MONTR...Technologies,Inc., the global leader in cryotherap...ounced that results previously presented from thre...product, Arctic Front(R),were published earlier t...
(Date:7/22/2008)...Study Demonstrates Feasibility and Efficacy of Tre...ry Liver Cancer, SAN FRANCISCO, and YONGIN-SI, So...(San Francisco, CA and Ottawa, Ontario), and its S...oday that novel findings from,a Phase I clinical t...onstrated that the product was well-tolerated and ...
(Date:7/22/2008)... SOUTH SAN FRANCISCO, Calif., July 22 /PRNewswire/...at it has completed patient enrollment,in its Phas...ability and,ammonia scavenging effects of HPN-100 ...phenylbutyrate) in patients with urea cycle disord...results in the fourth quarter,of this year., (Log...
Breaking Medicine Technology:InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3New Jersey Leaders Join Forces to Battle Chronic Disease 16998 1New Jersey Leaders Join Forces to Battle Chronic Disease 16998 2New Jersey Leaders Join Forces to Battle Chronic Disease 16998 3New Jersey Leaders Join Forces to Battle Chronic Disease 16998 4NYU Medical Center Changes Name to Honor Chairman of Board 26 Wife 4649 1NYU Medical Center Changes Name to Honor Chairman of Board 26 Wife 4649 2NYU Medical Center Changes Name to Honor Chairman of Board 26 Wife 4649 3NYU Medical Center Changes Name to Honor Chairman of Board 26 Wife 4649 4NYU Medical Center Changes Name to Honor Chairman of Board 26 Wife 4649 5Low Vitamin D Levels Linked to Leg Artery Blockages 16994 1Low Vitamin D Levels Linked to Leg Artery Blockages 16994 2Low Vitamin D Levels Linked to Leg Artery Blockages 16994 3Older people are nations happiest 16991 1Older people are nations happiest 16991 2
... in a randomized phase II/III clinical trial,antic...Newswire-FirstCall/ -- Cell,Therapeutics, Inc. (CT...s, which demonstrate that treatment with pixantron... cardiotoxicity, while,doxorubicin and mitoxantron...compared the cardiac side effects of equiactive do...
....--(BUSINESS WIRE)--Jun 26, 2007 - Sirtris,Pharmac... company,focused on discovering and developing sma...unced today that activation of SIRT1, a,member of ...t,against neurodegenerative diseases such as Alzhe...n animal models. These findings,appear in an artic...
Other Medicine Technology:Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 2Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 3Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 4Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 5Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 6Resveratrol Studies Suggest Broad Implications for SIRT1 Activation,in Neurodegenerative Diseases of Aging Such as Alzheimer's Disease 2Resveratrol Studies Suggest Broad Implications for SIRT1 Activation,in Neurodegenerative Diseases of Aging Such as Alzheimer's Disease 3
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: